Price$14.20+1.15 (+8.81%)
2026-03-042026-06-05
News · 26 weeks38-90%
2025-12-142026-06-07
Mix2090d
- SEC Filings9(45%)
- Insider6(30%)
- Earnings3(15%)
- Other2(10%)
Latest news
25 items- PRShoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare ConferenceGRAND RAPIDS, Mich., May 26, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, June 9, 2026. About Shoulder InnovationsShoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a
- SECSEC Form 10-Q filed by Shoulder Innovations Inc.10-Q - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- PRShoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year OutlookGenerates First Quarter Net Revenue Growth of 65% Year-Over-YearGRAND RAPIDS, Mich., May 13, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the first quarter ended March 31, 2026. First Quarter Financial HighlightsGenerated net revenue of $16.7 million in the first quarter, a 65% increase over the first quarter of 2025Achieved gross margin of 77.7% for the first quarter compare
- INSIDERCEO & Executive Chairman Ball Robert Joseph exercised 10,000 shares at a strike of $2.48, increasing direct ownership by 3% to 300,018 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECSEC Form DEF 14A filed by Shoulder Innovations Inc.DEF 14A - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- SECSEC Form DEFA14A filed by Shoulder Innovations Inc.DEFA14A - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- PRShoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral StemLatest Addition to I-Series Product Line Follows a Successful Limited Market Release and FDAClearance of Additional Fracture IndicationsGRAND RAPIDS, Mich., April 27, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced full commercial launch of the InSet™ I-135RFX Humeral Stem ("InSet™ I-135RFX"). The commencement of full launch follows a successful limited market release and receipt of additional FDA 5
- PRShoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti
- INSIDERSEC Form 4 filed by Ahearn Matthew Fraser4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- INSIDERChief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERDirector Buckman Paul exercised 45,606 shares at a strike of $2.26 and covered exercise/tax liability with 7,006 shares, increasing direct ownership by 192% to 58,704 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERDirector Buchholz Richard bought $14,840 worth of shares (1,000 units at $14.84), increasing direct ownership by 8% to 13,666 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERCEO & Executive Chairman Ball Robert Joseph bought $33,392 worth of shares (2,200 units at $15.18), increasing direct ownership by 0.80% to 278,866 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECSEC Form S-8 filed by Shoulder Innovations Inc.S-8 - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- SECSEC Form 10-K filed by Shoulder Innovations Inc.10-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- PRShoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial ResultsFourth Quarter Net Revenue Growth Accelerates to 65% Year-Over-YearGRAND RAPIDS, Mich., March 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the fourth quarter and full year ended December 31, 2025. Financial HighlightsGenerated net revenue of $14.4 million in the fourth quarter, a 65% increase over the prior year quarterGenerated net revenue of $47.3 million for the full y
- INSIDERSEC Form 3 filed by new insider Hykes Andrew3 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- PRShoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of DirectorsGRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board. "Drew is a proven healthcare leader, and we are thrilled to welcome him to S
- PRShoulder Innovations to Participate in the Canaccord Genuity 2026 Musculoskeletal ConferenceGRAND RAPIDS, Mich., Feb. 18, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will present at the Canaccord Genuity 2026 Musculoskeletal Conference. The presentation will take place at 2:00 p.m. CT / 12:00 p.m. PT on Tuesday, March 3, 2026. A live and archived version of the presentation will be available on the "Investor Relations" section of the Shoulder Innovations website at https
- PRShoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026GRAND RAPIDS, Mich., Feb. 12, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Tuesday, March 10, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026. Those interested in listening to the conference call may do so by dialing (877) 40
SI FAQ
7 questionsWhat does Shoulder Innovations Inc. do?
Silvergate Capital Corporation operates as a bank holding company for Silvergate Bank that provides banking products and services to business and individual clients in the United States and internationally. The company accepts deposit products, including interest and noninterest bearing demand accounts, money market and savings accounts, and certificates of deposit accounts. Its loan products comprise one-to-four family real estate loans, multi-family real estate loans, commercial real estate loans, construction loans, commercial and industrial loans, mortgage warehouse loans, and reverse...Where does SI stock trade?
Shoulder Innovations Inc. (SI) is listed on NYSE.What sector and industry is SI in?
Shoulder Innovations Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Shoulder Innovations Inc. go public?
Shoulder Innovations Inc. (SI) completed its IPO in 2025.What are analysts saying about SI?
Shoulder Innovations Inc. has had 8 recent analyst actions on file. The most recent action was from Goldman: Buy with a $2000.00 price target on 2025-08-25.What companies are similar to SI?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare SI side-by-side with any of them on Quantisnow.How can I track SI on Quantisnow?
Quantisnow aggregates Shoulder Innovations Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SI to receive live email and push alerts on every new disclosure.